Melittin has an inhibitory effect on TNF-α-induced migration of human aortic smooth muscle cells by blocking the

Yun-Jeong Jeong1, Hyun-Ji Cho, Key Whang

  • 1Research Institute of Biomedical Engineering and Department of Medicine, Catholic University of Daegu School of Medicine, Daegu 705-718, Republic of Korea.

Insights

Melittin, a bee venom component, inhibits matrix metalloproteinases-9 (MMP-9) and vascular smooth muscle cell migration. This suggests melittin

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Pharmacology

Background:

  • Matrix metalloproteinases-9 (MMP-9) is implicated in atherosclerosis and vascular smooth muscle cell (VSMC) migration.
  • Understanding the molecular mechanisms of anti-atherosclerotic compounds is crucial.

Purpose of the Study:

  • To investigate the anti-atherosclerotic effects of melittin in human aortic smooth muscle cells (HASMCs).
  • To elucidate the molecular mechanisms by which melittin impacts MMP-9 expression and VSMC migration.

Main Methods:

  • Assessed MMP-9 and MMP-2 secretion and TNF-α-induced MMP-9 expression in HASMCs.
  • Analyzed MMP-9 transcription levels and activity.
  • Investigated the effects of melittin on p38, ERK1/2, JNK, and Akt phosphorylation.
  • Utilized reporter gene assays, western blotting, and matrigel migration assays.

Main Results:

  • Melittin significantly suppressed MMP-9 and MMP-2 secretion.
  • Melittin inhibited TNF-α-induced MMP-9 expression and transcription.
  • Melittin blocked TNF-α-induced MMP-9 activity by inhibiting p38 and ERK1/2 phosphorylation.
  • Melittin suppressed NF-κB activation via the IκBα signaling pathway.
  • Melittin reduced TNF-α-induced HASMC migration.

Conclusions:

  • Melittin exhibits anti-atherosclerotic properties by inhibiting HASMC migration.
  • Melittin's mechanism involves the selective suppression of MMP-9 expression and activity.
  • Melittin represents a potential therapeutic agent for atherosclerosis.